Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Up – Here’s What Happened

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $26.59, but opened at $27.34. Chugai Pharmaceutical shares last traded at $26.2188, with a volume of 4,002 shares.

Chugai Pharmaceutical Stock Down 1.2%

The firm has a market capitalization of $86.46 billion, a price-to-earnings ratio of 32.84 and a beta of 0.63. The business has a 50-day moving average of $25.54 and a two-hundred day moving average of $24.11.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last posted its earnings results on Friday, October 24th. The company reported $0.23 EPS for the quarter. The business had revenue of $2.26 billion during the quarter. Chugai Pharmaceutical had a return on equity of 20.63% and a net margin of 32.74%. Equities analysts predict that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 EPS for the current fiscal year.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.